The 2000 FDA Science Forum focuses on one of the agency's highest priorities, the strength of the science base, to assure that all of our review, regulatory and policy decisions are grounded in science. The Forum plays a critical role in strengthening our science base by assuring that our scientists are trained in new developments in science and new technologies that are becoming part of our regulatory responsibility.

The major theme of this Forum is the Science of Safety, addressing the diverse disciplines of risk management of FDA. Session topics include: the Food Safety Initiative, postmarket surveillance, gender differences, risk communication, and contemporary issues in risk assessment. The Forum will bring FDA scientists together with industry, academia, government agencies, consumer groups and the public to explore the scientific and practical issues related to the safety evaluation and risk management of FDA-regulated products. Speakers and panelists will address emerging issues in the safety assessment of foods, drugs, biologics and medical devices. A poster session, sponsored by the FDA Chapter of Sigma Xi- the Scientific Research Society, will feature all areas of FDA science.

The 2000 FDA Scientific Achievement Awards will be presented to FDA scientists who have made exceptional contributions to the agency. Awardees from each of the Centers and ORA will be recognized along with FDA-level award recipients in the categories of Excellence in Analytical Science, Excellence in Laboratory Science, Excellence in Review Science and Outstanding Intercenter Scientific Collaboration.

The Office of the Senior Advisor for Science is proud to sponsor the 2000 FDA Science Forum on FDA and the Science of Safety: New Perspectives, as well as the Scientific Achievement Awards program. Thanks also to the American Association of Pharmaceutical Scientists, the FDA Chapter of Sigma Xi and the FDA Office of Women's Health for their support in sponsoring the Forum. Special thanks are given to the Forum organizing committee for arranging an excellent program and to the participants for making this an exciting and informative meeting.

Bernard A. Schwetz, D.V.M., Ph.D.
Acting Deputy Commissioner and Senior Advisor for Science

The following individuals are gratefully acknowledged for their contribution to the planning, organization and implementation of the 2000 FDA Science Forum.

FDA Senior Science Council

Bernard A. Schwetz, D.V.M., Ph.D., Acting Deputy Commissioner and Senior Advisor for Science
Norris E. Alderson, Ph.D., Center for Veterinary Medicine
Robert L. Buchanan, Ph.D. , Center for Food Safety and Applied Nutrition
Neil D. Goldman, Ph.D., Center for Biologics Evaluation and Research
Steven I. Gutman, M.D., Center for Devices and Radiological Health
Elizabeth D. Jacobson, Ph.D., Center for Devices and Radiological Health
Robert C. Livingston, Ph.D., Center for Veterinary Medicine
James T. MacGregor, Ph.D., Center for Drug Evaluation and Research
Donald E. Marlowe, Center for Devices and Radiological Health
Robert T. O'Neill, Ph.D., Center for Drug Evaluation and Research
Michael C. Olson, Ph.D., Office of Regulatory Affairs
Samuel W. Page, Ph.D., Center for Food Safety and Applied Nutrition
William Slikker, Jr., Ph.D., National Center for Toxicological Research
Terry C. Troxell, Ph.D., Center for Food Safety and Applied Nutrition
James F. Yager, Office of Regulatory Affairs

Science Forum Organizing Committee

Chair

Norris E. Alderson, Ph.D., Center for Veterinary Medicine, FDA

Session Chairs, Center for Biologics Evaluation and Research, FDA

Steven R. Bauer, Ph.D.
Elizabeth Sutkowski, Ph.D.

Center for Drug Evaluation and Research, FDA

Joseph F. Contrera, Ph.D.
Sandra L. Kweder, M.D.

Center for Devices and Radiological Health, FDA

Robert Gatling, Jr., M.S.
Thomas P. Gross, M.D., M.P.H.
David S. Shindell, Ph.D.

Center for Food Safety and Applied Nutrition, FDA

Robert H. Hall, Ph.D.
Dennis M. Keefe, Ph.D.

Center for Veterinary Medicine, FDA

Eric S. Dubbin, D.V.M.
Marcia L. Headrick, D.V.M., M.P.H.

National Center for Toxicological Research, FDA

David W. Gaylor, Ph.D.
Paul C. Howard, Ph.D.

Office of Regulatory Affairs, FDA

Thomas J. Arista
Elise A. Murphy

Office of the Senior Advisor for Science, FDA

Susan A. Homire, D.V.M.
Bernard A. Schwetz, D.V.M., Ph.D.

Sigma Xi

W. Howard Cyr, Ph.D., Center for Devices and Radiological Health, FDA

Office of Women's Health, FDA

Jonca C. Bull, M.D.

American Association of Pharmaceutical Scientists

David Pang, Ph.D.

American Association of Pharmaceutical Scientists

FDA Chapter, Sigma Xi

FDA Office of Women's Health